MAHMOOD KAZMI: Open Payments
NPI 1669438875 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,273 in 117 payments from 13 companies in 2025. Trend: 2023 $37,666 · 2024 $13,582 · 2025 $2,273
Food & beverage: $2,273
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $488 |
| Amgen Inc. | 16 | $317 |
| Otsuka America Pharmaceutical, Inc. | 26 | $301 |
| Celgene Corporation | 14 | $267 |
| PFIZER INC. | 11 | $218 |
| E.R. Squibb & Sons, L.L.C. | 6 | $136 |
| Amneal Pharmaceuticals LLC | 14 | $135 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Lundbeck LLC | 2 | $106 |
| Eisai Inc. | 3 | $70 |
Products named: CAPLYTA, UPLIZNA, REXULTI, ZEPOSIA, NURTEC ODT, COBENFY, CREXONT, Symbravo.
Industry payments across NY — which companies pay providers there.
